[PDF] frontiersin.org

[PDF][PDF] Progress and challenges of predictive biomarkers for immune checkpoint blockade

Y Lei, X Li, Q Huang, X Zheng, M Liu - Frontiers in Oncology, 2021 - frontiersin.org
Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …
被引用次数：85 相关文章
[HTML] frontiersin.org

[HTML][HTML] Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

Y Lei, X Li, Q Huang, X Zheng, M Liu - Frontiers in Oncology, 2021 - frontiersin.org
Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …
[HTML] nih.gov

[HTML][HTML] Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

Y Lei, X Li, Q Huang, X Zheng, M Liu - Frontiers in Oncology, 2021 - ncbi.nlm.nih.gov
Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

Y Lei, X Li, Q Huang, X Zheng… - Frontiers in oncology, 2021 - pubmed.ncbi.nlm.nih.gov
Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.

Y Lei, X Li, Q Huang, X Zheng, M Liu - Frontiers in Oncology, 2021 - europepmc.org
Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

Y Lei, X Li, Q Huang, X Zheng, M Liu - Frontiers in Oncology, 2021 - cir.nii.ac.jp
抄録< jats: p> Over the past decade, immune checkpoint blockade (ICB) therapy has
revolutionized the outlook for oncology with significant and sustained improvement in the …